| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |